Myricetin reduces neutrophil extracellular trap release in a rat model of rheumatoid arthritis, which is associated with a decrease in disease severity
Innate Immunity · 2024
DOI: 10.1177/17534259241255439 ↗Kurz gefasst
Fachartikel in der Zeitschrift Innate Immunity, 2024. Verfasst von Yiqin Shu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical College of Hubei Enshi College, Enshi, China. Hauptthemen laut MEDLINE: Extracellular Traps, Arthritis, Rheumatoid, Flavonoids, Protein-Arginine Deiminase Type 4. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Hubei Provincial Department of Education, National Natural Science Foundation of China, 湖北恩施学院教师类项目.
Abstract (Originalsprache)
Rheumatoid arthritis (RA) is a chronic disease characterized by joint inflammation and severe disability. However, there is a lack of safe and effective drugs for treating RA. In our previous study, we discovered that myricetin (MC) and celecoxib have a synergistic effect in the treatment of RA. We conducted in vitro and in vivo experiments to further investigate the effects and mechanisms of action of MC. Our findings demonstrated that MC treatment effectively reduced the release of neutrophil extracellular traps (NETs) and alleviated the inflammatory response in RA. Mechanistic studies showed that MC prevents the entry of PADI4 and MPO into the cell nucleus, thereby protecting DNA from decondensation. In a rat arthritis model, MC improved histological changes in ankle joints and suppressed NET-related signaling factors. In conclusion, MC protects the ankle joints against arthritis by inhibiting MPO and PADI4, thereby reducing NET release. The pharmacological mechanism of MC in RA involves the inhibition of NET release.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical College of Hubei Enshi College, Enshi, China.
- Institute of anti-rheumatism Tujia Medicine, Enshi, China.
- Hubei Provincial Key Laboratory of Rheumatic Disease Development and Intervention, Enshi, China.
ORCID-Profile: Hao Wu
Förderung
- Hubei Provincial Department of Education
- National Natural Science Foundation of China
- 湖北恩施学院教师类项目
Zitieren
APA
Shu, Y., Yang, R., Wen, H., Dong, Q., Chen, Z., Xiang, Y., & Wu, H. (2024). Myricetin reduces neutrophil extracellular trap release in a rat model of rheumatoid arthritis, which is associated with a decrease in disease severity. Innate Immunity. https://doi.org/10.1177/17534259241255439
Vancouver
Shu Y, Yang R, Wen H, Dong Q, Chen Z, Xiang Y, et al. Myricetin reduces neutrophil extracellular trap release in a rat model of rheumatoid arthritis, which is associated with a decrease in disease severity. Innate Immunity. 2024. doi:10.1177/17534259241255439
BibTeX
@article{Shu2024,
author = {Shu, Yiqin and Yang, Rui and Wen, Huijie and Dong, Qiannan and Chen, Zhiqi and Xiang, Yang and Wu, Hao},
title = {Myricetin reduces neutrophil extracellular trap release in a rat model of rheumatoid arthritis, which is associated with a decrease in disease severity},
journal = {Innate Immunity},
year = {2024},
doi = {10.1177/17534259241255439}
}
EUVIMED